advancing successful adoption of cpoe for chemotherapy were identified:• The need to investigate variances in workflows and practices in chemotherapy ordering and administration • The need to develop best-practice cpoe procurement and implementation guidance specifically for chemotherapy • The need to measure the effects of cpoe implementation in medical oncology ConclusionsAddressing the existing challenges in cpoe usability and adoption for chemotherapy, and accelerating successful migration to cpoe by cancer care providers requires future research focusing on workflow variations, chemotherapy-specific cpoe procurement needs, and implementation guidance needs.

As a part of a study that aims to evaluate and improve the labelling of containers for injectable drugs, Failure Mode and Effects Analysis (FMEA) was applied to the label reading process. Implementing a FMEA on a small-scale cognitive process involved various challenges including difficulties in representing the process, defining the failure modes, causes and effects, developing the rating scales for criticality, and rating the criticality of the failure modes. The failure modes were rated via two focus groups of healthcare professionals. The results highlight complexities and potential pitfalls with applying FMEA to the label reading process.

USP-FDA = United States Pharmacopoeia/US Food and Drug Administration. *Shall clauses are proposed as mandatory requirements; should clauses are considered recommendations. †Paraphrased from the Canadian Standards Association standard (CSA 1999).Using Human Factors Methods to Evaluate the Labelling of Injectable Drugs Kathryn Momtahan et al.

No abstract

No abstract